48,460
edits
Difference between revisions of "Atypical fibroxanthoma"
Jump to navigation
Jump to search
→IHC
(+images) |
(→IHC) |
||
| Line 76: | Line 76: | ||
**Scant staining not considered +ve. | **Scant staining not considered +ve. | ||
*Desmin -ve (done to r/o leiomyosarcoma). | *Desmin -ve (done to r/o leiomyosarcoma). | ||
Others: | |||
*Vimentin +ve. | |||
*SMA +ve.{{fact}} | |||
New ''et al.'' suggests:<ref name=pmid20713774>{{Cite journal | last1 = New | first1 = D. | last2 = Bahrami | first2 = S. | last3 = Malone | first3 = J. | last4 = Callen | first4 = JP. | title = Atypical fibroxanthoma with regional lymph node metastasis: report of a case and review of the literature. | journal = Arch Dermatol | volume = 146 | issue = 12 | pages = 1399-404 | month = Dec | year = 2010 | doi = 10.1001/archdermatol.2010.206 | PMID = 20713774 }}</ref> | |||
*Vimentin, SMA, CD68, cytokeratins, p63, desmin, CD99, CD10, S-100, CD117, LN-2, procollagen I. | |||
A panel: | |||
*Vimentin, SMA, CD68, CK18, EMA, CAM5.2, CK34betaE12, CK5/6, p63, desmin, CD99, CD10, S100, CD34. | |||
==Sign out== | ==Sign out== | ||